Abstract
The immune system plays an essential role in the pathogenesis, prevention and treatment of infectious diseases. Immunoinfectomics is an emerging field that addresses the interface between the host immune system and pathogens, and studies immunomes and infectomes (immunoinfectomes). Immune responses induced by microbial infections are complex phenomena that supervene on the levels of genomes, and as a result, infection and immunity ultimately depend on immunoinfectomes. The computational and mathematical approaches have shown practical benefits to convert all these complex data into sophisticated computer models of cellular gene and protein networks. The availability of the above methods has resulted in exciting new progress in the discovery and development of drugs and vaccines against infectious diseases with immunoinfectomic approaches. It has been demonstrated that only one single variable domain antibody fragment, referred to as VHH (variable heavy chain antibody) or nanobody, can interact with antigens. Nanobodies display several characteristics superior to the conventional antibodies, including their non-immunogenicity and high thermal and chemical stability. These characteristics make nanobodies strong candidates as targeting agents for infectious diseases. Recently, tremendous progress has been made in immune epitope mapping and vaccine candidate identification through the use of the immunoinfectomic approaches. These omic approaches provide powerful tools for advances in system biology of microbial infections and the discovery of novel antimicrobial agents.
Keywords: Alarmins, epitope, immunomes, infectomes, immunoinfectomes, nanobody, vaccine.
Anti-Infective Agents
Title:Exploring Novel Immunological Interventions Using Immunoinfectomics
Volume: 11 Issue: 2
Author(s): Qiqi Zhu, Lin Wang, Suoqin Tang, Hong Cao and Sheng-He Huang
Affiliation:
Keywords: Alarmins, epitope, immunomes, infectomes, immunoinfectomes, nanobody, vaccine.
Abstract: The immune system plays an essential role in the pathogenesis, prevention and treatment of infectious diseases. Immunoinfectomics is an emerging field that addresses the interface between the host immune system and pathogens, and studies immunomes and infectomes (immunoinfectomes). Immune responses induced by microbial infections are complex phenomena that supervene on the levels of genomes, and as a result, infection and immunity ultimately depend on immunoinfectomes. The computational and mathematical approaches have shown practical benefits to convert all these complex data into sophisticated computer models of cellular gene and protein networks. The availability of the above methods has resulted in exciting new progress in the discovery and development of drugs and vaccines against infectious diseases with immunoinfectomic approaches. It has been demonstrated that only one single variable domain antibody fragment, referred to as VHH (variable heavy chain antibody) or nanobody, can interact with antigens. Nanobodies display several characteristics superior to the conventional antibodies, including their non-immunogenicity and high thermal and chemical stability. These characteristics make nanobodies strong candidates as targeting agents for infectious diseases. Recently, tremendous progress has been made in immune epitope mapping and vaccine candidate identification through the use of the immunoinfectomic approaches. These omic approaches provide powerful tools for advances in system biology of microbial infections and the discovery of novel antimicrobial agents.
Export Options
About this article
Cite this article as:
Zhu Qiqi, Wang Lin, Tang Suoqin, Cao Hong and Huang Sheng-He, Exploring Novel Immunological Interventions Using Immunoinfectomics, Anti-Infective Agents 2013; 11 (2) . https://dx.doi.org/10.2174/2211352511311020004
DOI https://dx.doi.org/10.2174/2211352511311020004 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Zinc Homeostasis-regulating Proteins: New Drug Targets for Triggering Cell Fate
Current Drug Targets Quinone Methide Bioactivation Pathway: Contribution to Toxicity and/or Cytoprotection?
Current Organic Chemistry Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma
Current Molecular Pharmacology Beneficial Effect of Peptides from Microalgae on Anticancer
Current Protein & Peptide Science SAR, QSAR and Docking of Anticancer Flavonoids and Variants: A Review
Current Topics in Medicinal Chemistry Targeting Trail Towards the Clinic
Current Drug Targets Drug Targeting to the Brain - A Review
Current Nanoscience Cyclodextrins and their Derivatives as Carrier Molecules in Drug and Gene Delivery Systems
Current Organic Chemistry Developments in the Application of 1,2,3-Triazoles in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters
Recent Patents on Nanotechnology Technetium-99m-based Radiopharmaceuticals in Sentinel Lymph Node Biopsy: Gynecologic Oncology Perspective
Current Pharmaceutical Design The Genetic Basis of Kidney Cancer: Why is Tuberous Sclerosis Complex Often Overlooked?
Current Molecular Medicine Dichotomous Life of DNA Binding High Mobility Group Box1 Protein in Human Health and Disease
Current Protein & Peptide Science Concomitant Expression of Inhibitory Molecules for T cell Activation Predicts Poor Survival in Patients with Esophageal Squamous Cell Carcinoma
Current Cancer Drug Targets Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer
Current Cancer Drug Targets Impact of Cellular Senescence in Aging and Cancer
Current Pharmaceutical Design Protein/ Hormone Based Nanoparticles as Carriers for Drugs Targeting Protein-Protein Interactions
Current Topics in Medicinal Chemistry Inhibitory Effects of Substituted Cinnamic Acid Esters on Mushroom Tyrosinase
Letters in Drug Design & Discovery Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer
Current Molecular Medicine Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes
Current Genomics